Also Holding Ag · SIX:ALSN

Also — H1 2022 Earnings Presentation

9 slides from Also's earnings presentation, Jul 20, 2022

  1. Slide 1: H1 Results

    H1 RESULTS 20. July 2022

  2. Slide 2: Disclaimer

    DISCLAIMER This presentation is not an offer or a solicitation to purchase or invest in any shares of ALSO Holding AG (the "Company "), nor shall it or any part of it nor the fact of its distribution form the basis of, or be relied on in connection with, any contract or investment decision. This pre

  3. Slide 3: Sales 3S H1 2021 vs H1 2022

    SALES 3S H1 2021 V H1 2022 * Supply, Solutions and Services Net Sales Unique Users (in m) (in m €) +31% H1 2022 H1 2021 Delta 3.4 3,4 Net sales before IFRS 15 +1% 2.6 (PvA) 5 974 5 923 2,6 Supply 3 851 4 121 -7% Solutions 1 703 1 509 +13% Service 421 294 +43% H1 2021 H1 2022 * before IFRS 15 (PvA) M

  4. Slide 4: H1 in a nutshell

    H1 IN A NUTSHELL ► EBITDA +11.3% ► Due to stock increase to guarantee availability ROCE 13.8% ► Net Sales with 5 525 m€ on the same high level as H1 2021 (-0.5%) ► Supply -6.4% ► Solutions +16.8% ► Services +9.3% ► Increased Gross Profit (+2.6%) Media- and Investor-Conference H1 2022 20.07.2022 4

  5. Slide 5: Development EBITDA

    DEVELOPMENT EBITDA Adjusted EBITDA H1 2021/2022 in m € 19 127.5 114.6 115.3 116.5 -0.7 -8 H1 2021 FX effects H1 2021 H1 2022 FX effects Sale H1 2022 reported 2021 adjusted adjusted 2022 Real estate reported Media- and Investor-Conference H1 2022 20.07.2022 5

  6. Slide 6: Effect of investments

    EFFECT OF INVESTMENTS Adjusted EBITDA H1 2021/2022 in m € 10.6% 127.5 9.8 126.3 Main cost of 114.6 0.7 115.3 8 investment: -19 ► New staff ► Retention costs current staff ► IT H1 2021 FX effects H1 2021 H1 2022 Sale FX effects Invest- H1 2022 reported 2021 adjusted reported Real estate 2022 ments ad

  7. Slide 7: Development cash

    DEVELOPMENT CASH Cash in m € 40.9 152.3 -5.5 346.4 -378.7 -18.9 12.2 75.2 -73.5 Other non-cash Exchange D&A items differences Media- and Investor-Conference H1 2022 20.07.2022 7

  8. Slide 8: Targets confirmed

    TARGETS CONFIRMED Target 2022 Midterm Target EBITDA EBITDA 275–295 m€ 330–420 m€ ROCE ROCE > 20% 20% > Media- and Investor-Conference H1 2022 20.07.2022 8

  9. Slide 9: Thank you!

    THANK YOU! de o)(ooG) BEBEEE = (eae) (aaa)

ALSO Holding — H1 2022 Earnings Presentation on 6ix